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In chronic lymphocytic leukaemia (CLL) bone marrow trephine biopsy (BMT) is not
required for diagnosis but can have a significant prognostic value and can be used
for the detection of the minimal residual disease (MRD) and for assessment of the
effectiveness of the treatment applied. The aim of the study was to evaluate the
morphological changes in bone marrow after treatment with purine nucleoside
analogues cladribine and fludarabine. Bone marrow trephine biopsy was taken
routinely from 15 patients with CLL. Bone marrow trephine biopsy was performed
on every patient before as well as after chemotherapy. The number of cell ele-
ments of the marrow (the degree of atrophy), the patterns of bone marrow infil-
tration, the presence of reticulin and collagen fibres and the disturbances in bone
marrow stroma were assessed. The infiltration of bone marrow by neoplastic cells
was observed in all the patients before administration of chemotherapy. The infil-
tration was followed by an increase in the number of reticulin fibres. After the
treatment a regression of the reticulin fibres was observed with the lessening of
the infiltration. After the treatment the levels of marrow infiltrate were decreased.
Increased hypoplasia of the bone marrow was observed after the chemotherapy.
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INTRODUCTION
Chronic lymphocytic leukemia (CLL) is the most
common form of leukaemia in adults to occur in
Western societies [10]. For its diagnosis bone mar-
row trephine biopsy (BMT) is not required. Howev-
er, histopathological assessment of bone marrow can
be of significant prognostic value and is strongly
recommended by the National Cancer Institute-Spon-
sored Working Group on CLL guidelines [3]. In clini-
cal studies BMT is performed before the start of treat-
ment as well as after the treatment. It is a useful
diagnostic device for the assessment of the minimal
residual disease (MRD) and the effectiveness of the
applied treatment [1, 6, 14]. Histopathological exa-
mination allows for assessment of the influence of
chemotherapy on haematopoietic cell lineages and
helps to assess the haematopoietic inductive mi-
croenvironment (HIM), for example the degree of
reticulin fibrosis (increase in the number of argento-
phylic fibres) and collagen fibrosis (increase in the
number of  collagen fibres) of the bone marrow [5].
Bone marrow trephine biopsy is used for the assess-
ment of bone marrow involvement. In CLL there are
3 types of different infiltration patterns of leukae-
mic cells that can be recognised in BMT specimens:
nodular, diffuse, and interstitial [9]. Nodular or in-
terstitial patterns may be grouped together and de-
scribed as non-diffuse.
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In the last 20 years new therapeutic methods in
CLL have emerged due to the introduction of the
new generation of drugs which can be used in sin-
gle or combination chemotherapy. New purine nu-
cleoside analogues (PNA) are such agents and this
group consists of: 2’-deoxycoformycin (pentostatin),
2-chlorodeoxyadenosine (2-CdA, cladribine) and flu-
darabine (FAMP). Many studies have proved their
effectiveness in terms of the overall response (OR)
to the treatment and even the achievement of com-
plete remission (CR) [7, 12]. Assessment of nodular
partial remission (nPR) in the bone marrow may be
performed with the use of BMT simultaneously with
CR assessment after the treatment [1, 14].
The aim of the study was to evaluate the mor-
phological changes in bone marrow after PNA treat-
ment (2-CdA or FAMP).
MATERIAL AND METHODS
Using the Jamshidi type needle, bone marrow
trephine biopsy was taken routinely from the pos-
tero-superior iliac spine from 15 previously untreat-
ed patients with CLL in the 2nd, 3rd or 4th clinical
stage of the disease according to the Rai staging
system. Bone marrow trephine biopsy was per-
formed in every patient before as well as after che-
motherapy. The group studied included 6 females
and 9 males aged 35 to 72 years. FAMP was ad-
ministered to 3 patients and 2-CdA to the remain-
ing 12. Bone marrow tissue material was fixed in
so-called “Oxford solution”. After fixing (48–72
hours), the oval-shaped fragments of bone marrow
from 1.5 to 2.5 cm in length and 1 mm in diameter
were put into paraffin bars. Thin sections at 5 µm
were cut by the use of microtom. Haematoxylin and
eosin were applied in routine staining techniques
[15]. The number of cell elements of the marrow
(the degree of atrophy), the presence of lymphoid
infiltration and the presence of argentophilic and
collagen fibres was assessed. For the assessment of
reticulin and collagen fibrosis Gomori’s silver im-
pregnation and the Azan method were applied. The
degree of reticulin fibrosis was measured accord-
ing to Kundel’s criteria [8] in the Baumeister modi-
fication [2] and expressed in grades, where N was
defined as single argentophylic reticulin fibres:
Grade 1 — insignificant, delicate, diffused foci of
argentophylic fibres with single reticular foci; Grade
2 — visible reticular foci of argentophylic fibres in
few microscopic fields; Grade 3 — diffuse reticulin,
visible wide argentophylic fibres without collagen
fibres; Grade 4 — collagen fibrosis. The morpho-
metric examination was carried out using the im-
age analysis set DP 12. Statistical analysis of the
results was assessed by the Wilcoxon matched pairs
test and the Mann-Whitney U test using the com-
puter program Statistica Pl. The study was approved
by the Bioethical Committee of the Medical Univer-
sity of Bialystok NoR-I-003/200/2003.
RESULTS
Before the administration of chemotherapy the
infiltration of bone marrow by neoplastic cells was
observed in all the patients. In 13 (87%) patients the
marrow was infiltrated in a diffuse pattern (Fig. 1)
and in 2 patients in a nodular pattern (13%). After
the treatment diffuse infiltration persisted in 4 pa-
tients, and only in 2 patients was the presence of
single neoplastic cells observed. The nodular infil-
tration persisted in 9 patients (Fig. 2). In 9 cases
statistically significant differences (p < 0.05) were
Figure 2. BM trephine section, CLL, nodular partial remission.
H-E. Paraffin-embedded.
Figure 1. BM trephine section, CLL, diffuse infiltration. H-E. Pa-
raffin-embedded.
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observed between the extent of the infiltration be-
fore and after the treatment (Fig. 3). Before the
treatment the infiltration was accompanied by an
increase in the number of reticulin fibres. In 6 pa-
tients (40%) Grade 1 fibrosis was diagnosed, while
Grade 2 (Fig. 4) was observed in 3 patients (20%).
After the treatment the regression of argentophylic
fibres was noticed in 8 patients and in the remain-
ing persons features of Grade 1 were observed.
Only in 1 patient (7%), diagnosed Grade 3 of reti-
culin fibrosis, was the presence of collagen fibro-
sis noticed after the treatment (Fig. 5). After the
treatment Grades 2 and 3 were not observed (Fig. 6).
In 8 patients features of haematopoietic cell defi-
ciency was noticed before the chemotherapy and
it either persisted or appeared after the treatment
in 11 patients. Inhibition of haematopoietic cell
lineage maturation was assessed in 6 patients.
Figure 3. The level of lymphoid infiltration of bone marrow in patients with CLL before and after chemotherapy.
Figure 4. BM trephine section, CLL, showing Grade 2 reticulin
deposition. Gomori. Paraffin-embedded.
Figure 5. BM trephine section, CLL, showing Grade 4 collagen
deposition. Azan. Paraffin-embedded.
Figure 6. The frequency of occurrence of reticulin and collagen
fibrosis in patients with CLL before and after chemotherapy.
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DISCUSSION
The new generation of anti-neoplastic drugs such
as PNA is highly active in CLL [10]. Patients with CLL
are considered in nPR when they are in remission
after chemotherapy. In studying the significance of
the levels of bone marrow lymphoid infiltration in
CLL with nPR after treatment with nucleoside ana-
logues Oudat et al. [11] observed nodular infiltra-
tion of bone marrow in 82% of patients and mixed
infiltration in 18% (nodular and interstitial). Before
treatment diffuse infiltration he had only observed
in 36% of the patients and non-diffuse infiltration in
64%. In our study 73% of the patients responded to
the treatment and, although no infiltration with leu-
kaemic cells was observed in 13% of the patients,
nodular infiltration was seen in 60%. These values
were of statistical significance (p < 0.05). This fin-
ding would seem to be of particular importance be-
cause the diffuse infiltration was observed in 87%
of the patients before treatment. The patients with
diffuse infiltration tend to develop a more advanced
form of the disease and have a relatively poor prog-
nosis in comparison with those patients with non-
diffuse infiltrative patterns [1, 13]. Thus it seems es-
pecially important that the treatment applied has
caused nPR in most cases. Nodular partial remission
is frequently seen in CLL patients. The significance
of the level of bone marrow infiltration with lym-
phoid cells in the form of nPR is not fully understood
[11].
Reticulin fibrosis after the treatment is reversible
and rebuilding of the proper bone marrow structure
occurs. However, in some cases in which collagen
fibres are present only partial regression is possible.
Reticulin fibrosis frequently occurs in areas of infil-
tration of the lymphatic system and collagen fibro-
sis is often present [1, 14]. In our study the infiltra-
tion was followed by an increase in the number of
reticulin fibres in most of the patients. After the treat-
ment a regression of the reticulin fibres with lessen-
ing of the infiltration was observed. Only in 1 pa-
tient with Grade 3 reticulin fibrosis diagnosed prior
to the treatment was a sudden progression after
treatment observed along with the appearance of
collagen fibrosis. However, this patient had diffuse
infiltration of the bone marrow before the treatment
and did not respond to the treatment while the in-
filtration persisted.
Purine nucleoside analogues are not free of side-
effects. Myelosuppression and infections are among
most common [4, 12]. In our study an increased hy-
poplasia of bone marrow was observed after the
treatment. Moreover, in a few patients inhibition of
haematopoietic cell lineage maturation was ob-
served. These changes may lead to persisting throm-
bocytopoenia, neutropoenia and anaemia in patients
administered purine analogues. Apart from quanti-
tative changes in the haematopoietic system, quali-
tative changes appear through the disturbance of
the platelet function, especially through impairment
of their antibacterial activity. These effects of PNA
may be responsible for frequent infections, apart
from the immunosuppressive qualities of those
drugs.
Bone marrow trephine biopsy is a more sensitive
method for the detection of infiltration in B cell disor-
ders than bone marrow aspirates but flow cytometry
may, in turn, be slightly more sensitive than BMT in
detecting MRD in CLL [14]. However, BMT is espe-
cially useful for the initial analysis of the effects of
administered chemotherapy on bone marrow and
helps in assessing the inhibition of haematopoietic
cell lineage maturation, the degree of atrophy and
the presence of reticulin and collagen fibrosis after
chemotherapy.
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